Adalimumab-induced Autoimmune Hepatitis

Tomer Adar, Meir Mizrahi, Orit Pappo, Anat Scheiman-Elazary, Oren Shibolet

Research output: Contribution to journalArticlepeer-review


Antitumor necrosis factor antibodies are widely used in the treatment of autoimmune diseases. We describe the occurrence of autoimmune hepatitis in a patient treated with adalimumab, a fully human IgG antibody against tumor necrosis factor, for psoriatic arthritis. The patient made a full recovery after discontinuation of adalimumab and treatment with steroids. This is the first reported case of adalimumab-induced autoimmune hepatitis.

Original languageEnglish
Pages (from-to)e20-e22
JournalJournal of Clinical Gastroenterology
Issue number1
StatePublished - Jan 2010
Externally publishedYes


  • Adalimumab
  • Anti-TNF
  • Autoimmune hepatitis


Dive into the research topics of 'Adalimumab-induced Autoimmune Hepatitis'. Together they form a unique fingerprint.

Cite this